| 日付 |
時間 |
ソース |
タイトル |
|---|
| 2024/5/17 | 21:00 | BW | Azitra, Inc. Announces Positive Preclinical Data from ATR-04.. |
| 2024/5/10 | 21:00 | BW | Azitra, Inc. Announces Positive Preclinical Data of ATR-12.. |
| 2024/5/10 | 06:05 | EDGAR2 | Form 8-K - Current report |
| 2024/5/10 | 06:03 | EDGAR2 | Form 10-Q - Quarterly report [Sections 13 or 15(d)] |
| 2024/5/10 | 06:00 | BW | Azitra, Inc. Announces Q1 2024 Financial Results and.. |
| 2024/4/23 | 05:30 | BW | Azitra, Inc. Announces New Preclinical Data to be Presented.. |
| 2024/4/19 | 05:15 | BW | Azitra, Inc. to Present New Data at Three Upcoming.. |
| 2024/3/16 | 05:15 | BW | Azitra, Inc. Announces Full Year 2023 Financial Results and.. |
| 2024/2/27 | 06:10 | EDGAR2 | Form SC 13G/A - Statement of acquisition of beneficial.. |
| 2024/2/27 | 06:05 | EDGAR2 | Form SC 13G - Statement of acquisition of beneficial.. |
| 2024/2/17 | 06:05 | BW | Azitra, Inc. Announces Closing of Public Offering |
| 2024/2/16 | 10:42 | EDGAR2 | Form 4 - Statement of changes in beneficial ownership of.. |
| 2024/2/16 | 10:39 | EDGAR2 | Form 4 - Statement of changes in beneficial ownership of.. |
| 2024/2/16 | 10:38 | EDGAR2 | Form 4 - Statement of changes in beneficial ownership of.. |
| 2024/2/16 | 06:44 | EDGAR2 | Form 424B5 - Prospectus [Rule 424(b)(5)] |
| 2024/2/14 | 23:15 | EDGAR2 | Form 8-K - Current report |
| 2024/2/14 | 12:09 | BW | Azitra, Inc. Announces Pricing of Public Offering |
| 2024/1/20 | 01:08 | EDGAR2 | Form FWP - Filing under Securities Act Rules 163/433 of free.. |
| 2024/1/19 | 23:19 | EDGAR2 | Form S-1 - General form for registration of securities under.. |
| 2024/1/16 | 23:00 | BW | Azitra, Inc. Strengthens Intellectual Property Portfolio.. |
| 2024/1/03 | 23:00 | BW | Azitra, Inc. to Present at Biotech Showcase 2024 and the.. |
| 2023/12/05 | 06:06 | EDGAR2 | Form S-8 - Securities to be offered to employees in employee.. |
| 2023/11/15 | 06:30 | BW | Azitra, Inc. Announces Third Quarter 2023 Financial Results.. |
| 2023/10/16 | 21:00 | BW | Azitra to Present at the ThinkEquity Conference |
| 2023/10/04 | 05:05 | EDGAR2 | Form 4 - Statement of changes in beneficial ownership of.. |
| 2023/10/04 | 05:05 | EDGAR2 | Form 4 - Statement of changes in beneficial ownership of.. |
| 2023/10/04 | 05:05 | EDGAR2 | Form 4 - Statement of changes in beneficial ownership of.. |
| 2023/10/04 | 05:05 | EDGAR2 | Form 4 - Statement of changes in beneficial ownership of.. |
| 2023/8/29 | 21:00 | PRNUS | Azitra to Present at the H.C. Wainwright 25th Annual Global.. |
| 2023/8/15 | 05:11 | EDGAR2 | Form 8-K - Current report |
| 2023/8/15 | 05:10 | EDGAR2 | Form 10-Q - Quarterly report [Sections 13 or 15(d)] |
| 2023/8/15 | 05:05 | PRNUS | Azitra, Inc. Announces Second Quarter 2023 Financial Results.. |
| 2023/7/20 | 05:05 | PRNUS | Azitra Adds Biotech Leaders Barbara Ryan and John Schroer to.. |
| 2023/7/12 | 05:05 | EDGAR2 | Form 8-K - Current report |
| 2023/7/12 | 05:05 | PRNUS | Azitra, Inc. Appoints Travis Whitfill as Chief Operating.. |
| 2023/7/08 | 05:05 | EDGAR2 | Form 8-K - Current report |
| 2023/7/04 | 04:04 | EDGAR2 | Form SC 13D - General statement of acquisition of beneficial.. |
| 2023/6/30 | 05:56 | EDGAR2 | Form 4/A - Statement of changes in beneficial ownership of.. |
| 2023/6/22 | 07:46 | PRNUS | Azitra, Inc. Announces Closing of Initial Public Offering |
| 2023/6/16 | 08:04 | PRNUS | Azitra, Inc. Announces Pricing of Initial Public Offering |
Hot Features
プレミアム
登録して、同じ考えを持つ投資家と議論するためのアクティブなフォーラムで相互作用するためのアクティブなフォーラムに参加してください。
